跳至主要内容
临床试验/EUCTR2011-004953-17-DE
EUCTR2011-004953-17-DE进行中(未招募)不适用

Measurement of epidermal and dermal thickness under therapy with Pimecrolimus 1 % Creme (Elidel® 1 % Creme), Hydrocortisonacetat 1 % Creme (Hydrogalen® Creme), Betamethasonvalerat 0,1 % Creme (Betagalen® Creme), Methylprednisolonaceponat 0,1 % Creme (Advantan® Creme), Dermatop® Basecreme and without therapy by optical coherencetomography (OCT) and 20-MHZ-ultrasound.

Technical university Dresden0 个研究点开始时间: 2011年12月9日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - age 18-40 years
  • - health volunteers
  • - normal dermis
  • - written accordance of the test person
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 30
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - pregnant or nursing woman,
  • - missing contraception,
  • - external or systemic therapy in the last 6 months with special drugs (Retinoids, Glucocorticoisteroids, Calcineurininhibitors,..)
  • - disease of the epidermis (atopic dermatitis, psoriasis, erythrodermie,...), skin disease who makes topical application of cremes impossible
  • - intensive UV-exposition or UV-therapy within the last 4 weeks or in trial,
  • - simultaneous participance in other clinical studies and participation in a second trial within the last 30 days
  • -hypersensitivity against Elidel®, Hydrogalen® Creme, Betagalen® Creme, Advantan® Creme, or Dermatop® Basecreme,
  • - disease with anticipate a therapy with Elidel®, Betagalen® Creme, Ecural® Fettcreme, Hydrogalen® Creme, Advantan® Creme or Dermatop® Basecreme,
  • - use of immunsuppressive drugs, or severe systemic disease,
  • - non-compliance,
  • -vaccination within the last 14 days

研究者

发起方
Technical university Dresden

相似试验